SEC to discuss India’s first indigenously developed vaccine against cervical cancer
english.khabarhub.com · Wed Jun 15 01:26:16 GMT 2022
Vaccine/Image for Representation
NEW DELHI: The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India (SII) will be discussed by the Subject expert committee on Wednesday.
Read full story at source (english.khabarhub.com)